Evidence map›Paper›PMID 23123252›Full record

ArticleChemico-biological interactions2013

Proteomic analysis of adducted butyrylcholinesterase for biomonitoring organophosphorus exposures.

Judit Marsillach, Edward J Hsieh, Rebecca J Richter, Michael J MacCoss, Clement E Furlong

Abstract read
In one paragraph

Article in Chemico-biological interactions, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Xenobiotic Hazards in Aircraft Cabin Air.Journal of xenobiotics · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Judit MarsillachDept of Medicine (Division of Medical Genetics), University of Washington, 98195 Seattle, WA, USA. jmarsi@uw.edu
Edward J Hsieh
Rebecca J Richter
Michael J MacCoss
Clement E Furlong
University of Washington · US

Funding

WILDLIFE BIOMARKER APPLICATIONS TO REMEDIATION DECISION MAKINGP42ES004696 · NIEHS · UNIVERSITY OF WASHINGTON · PI GALLAGHER, EVAN P · 1987 to 2021
$51.2M
XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI ALI SHOJAIE · 1995 to 2026
$42.5M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
STUDY OF CELLULAR &MOLECULAR ASPECTS OF PESTICIDE NEURODEVELOPMENTAL TOXICITYP01ES009601 · NIEHS · UNIVERSITY OF WASHINGTON · PI FAUSTMAN, ELAINE M · 1999 to 2013
$8.7M
STRUCTURE/FUNCTION OF THE HUMAN PON1 POLYMORPHISMR01ES009883 · NIEHS · UNIVERSITY OF WASHINGTON · PI FURLONG, CLEMENT EUGENE · 1999 to 2013
$5.3M
Skyline Targeted Proteomics EnvironmentR01GM103551 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2020
$3.4M
NIEHS NIH HHS 5P42ES04696NIEHS NIH HHS ES09601/EPA-R826886NIEHS NIH HHS NIEHS P30ES07033NIEHS NIH HHS P01 ES009601NIEHS NIH HHS P30 ES007033NIEHS NIH HHS P42 ES004696NIEHS NIH HHS R01 ES009883NIEHS NIH HHS R01ES09883NIGMS NIH HHS P41 GM103533NIGMS NIH HHS P41GM103533NIGMS NIH HHS R01 GM103551
6 · The paper itself

Abstract

Organophosphorus (OP) compounds include a broad group of toxic chemicals such as insecticides, chemical warfare agents and antiwear agents. The liver cytochromes P450 bioactivate many OPs to potent inhibitors of serine hydrolases. Cholinesterases were the first OP targets discovered and are the most studied. They are used to monitor human exposures to OP compounds. However, the assay that is currently used has limitations. The mechanism of action of OP compounds is the inhibition of serine hydrolases by covalently modifying their active-site serine. After structural rearrangement, the complex OP inhibitor-enzyme is irreversible and will remain in circulation until the modified enzyme is degraded. Mass spectrometry is a sensitive technology for analyzing protein modifications, such as OP-adducted enzymes. These analyses also provide some information about the nature of the OP adduct. Our aim is to develop high-throughput protocols for monitoring OP exposures using mass spectrometry.

Indexed as

AgricultureButyrylcholinesteraseCatalytic DomainCholinesterase InhibitorsEnvironmental ExposureEnvironmental MonitoringHigh-Throughput Screening AssaysHumansOccupational ExposureOrganophosphorus CompoundsProteomicsSerineTandem Mass SpectrometryButyrylcholinesteraseCholinesterase InhibitorsOrganophosphorus CompoundsSerine

Identifiers

PMID23123252
PMCPMC4108156
OpenAlexW2002441749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.